Globally, Pfizer has said it could have 50 million doses by year’s end.Ī different projection, according to information presented to the National Academy of Medicine in late November, said about 25 million doses could become available in the US in December, 30 million in January and 35 million more in February and March. “And production of course would continue to ramp up after that.” “We expect to have about 40 million doses of these two vaccines available for distribution pending FDA authorization - enough to vaccinate about 20 million of our most vulnerable Americans,” Azar said at a Nov. Millions of doses of the Pfizer and Moderna vaccines should be available to certain groups by the end of December, according to Health and Human Services Secretary Alex Azar. Here is a realistic timeline of when an effective vaccine could be on tap for all Americans.
The promising results have prompted both drugmakers to seek approval from the Food and Drug Administration for emergency use - with the shots expected to be distributed within 24 hours if given the green light.īut while federal health officials remain optimistic that help is on the way, the availability of vaccines doesn’t equate to an immediate cure to coronavirus. Vaccine candidates from Pfizer and its German partner BioNTech, and from Moderna have shown to be 95 percent effective in ongoing trials. With the dark winter months looming, there’s one glimmer of hope in the fight against the COVID-19 crisis.
Pair of scientists win Nobel Prize in medicine for enabling development of mRNA vaccines More than half of US adults won’t get updated COVID booster vaccine: survey Pfizer’ jabįlu shot myths make us sick - experts bust 6 of the major ones
Aaron Rodgers takes shot at Travis Kelce with ‘Mr.
0 kommentar(er)
